{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:29:07Z","timestamp":1782538147711,"version":"3.54.5"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.coi.2025.102581","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T23:29:18Z","timestamp":1748647758000},"page":"102581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Epigenetics of atopic dermatitis: pathogenesis and therapeutic prospects"],"prefix":"10.1016","volume":"95","author":[{"given":"Chi","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7104-5490","authenticated-orcid":false,"given":"Cong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102581_bib1","doi-asserted-by":"crossref","unstructured":"Laughter, M., et al.: The Global Burden of Atopic Dermatitis: Lessons From the Global Burden of Disease Study 1990\u20132017. 2021. 184(2): p. 304\u2013309.","DOI":"10.1111\/bjd.19580"},{"key":"10.1016\/j.coi.2025.102581_bib2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(24)02519-4","article-title":"Atopic dermatitis","volume":"405","author":"Guttman-Yassky","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2025.102581_bib3","doi-asserted-by":"crossref","unstructured":"Yew, YW, JP Thyssen, and J.I. Silverberg: A Systematic Review and Meta-Analysis of the Regional and Age-Related Differences In Atopic Dermatitis Clinical Characteristics; 2019. 80(2): p. 390\u2013401.","DOI":"10.1016\/j.jaad.2018.09.035"},{"key":"10.1016\/j.coi.2025.102581_bib4","doi-asserted-by":"crossref","unstructured":"Schuler IV, CF, et al.: Novel Insights Into Atopic Dermatitis; 2023. 151(5): p. 1145\u20131154.","DOI":"10.1016\/j.jaci.2022.10.023"},{"key":"10.1016\/j.coi.2025.102581_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.coi.2025.102581_bib6","doi-asserted-by":"crossref","unstructured":"You, S, et al.: Allergen Immunotherapy in Patients With Atopic Dermatitis Allergic to House Dust Mite: A Systematic Review and Meta-Analysis; 2024. 137(18): p. 2245\u20132247.","DOI":"10.1097\/CM9.0000000000003017"},{"key":"10.1016\/j.coi.2025.102581_bib7","doi-asserted-by":"crossref","unstructured":"Demessant-Flavigny, AL, et al.: Skin Microbiome Dysbiosis and the Role of Staphylococcus aureus in Atopic Dermatitis in Adults and Children: A Narrative Review; 2023. 37: p. 3\u201317.","DOI":"10.1111\/jdv.19125"},{"key":"10.1016\/j.coi.2025.102581_bib8","doi-asserted-by":"crossref","unstructured":"Sood, S, et al.: Role of Epigenetics in Corneal Health and Disease; 2024: p. 101318.","DOI":"10.1016\/j.preteyeres.2024.101318"},{"key":"10.1016\/j.coi.2025.102581_bib9","doi-asserted-by":"crossref","unstructured":"Zhang, D, et al.: Targeting Epigenetic Modifications in Parkinson's Disease Therapy; 2023. 43(5): p. 1748\u20131777.","DOI":"10.1002\/med.21962"},{"key":"10.1016\/j.coi.2025.102581_bib10","doi-asserted-by":"crossref","unstructured":"Fasano, S, et al: Precision Medicine in Systemic Lupus Erythematosus. 2023. 19(6): p. 331\u2013342.","DOI":"10.1038\/s41584-023-00948-y"},{"key":"10.1016\/j.coi.2025.102581_bib11","doi-asserted-by":"crossref","unstructured":"Liu, F, et al.: Technologies and Applications of Single-Cell DNA Methylation Sequencing; 2023. 13(8): p. 2439.","DOI":"10.7150\/thno.82582"},{"key":"10.1016\/j.coi.2025.102581_othref0050","doi-asserted-by":"crossref","unstructured":"Wu, Y-L, et al.: Epigenetic Regulation in Metabolic Diseases: Mechanisms and Advances in Clinical Study. 2023. 8(1): p. 98. \u2022 diseases: mechanisms and advances in clinical study. 2023;8(1):98. Wu et al. (2023) synthesized the core mechanisms of epigenetic regulation and dissected the key influence of DNA methylation in numerous biological processes.","DOI":"10.1038\/s41392-023-01333-7"},{"key":"10.1016\/j.coi.2025.102581_bib13","doi-asserted-by":"crossref","unstructured":"Ruan, B, et al.: DNMT Aberration-Incurred GPX4 Suppression Prompts Osteoblast Ferroptosis and Osteoporosis; 2024. 12(1): p. 68.","DOI":"10.1038\/s41413-024-00365-1"},{"key":"10.1016\/j.coi.2025.102581_bib14","doi-asserted-by":"crossref","unstructured":"Zhu, L, et al.: Loss of Claudin-1 Incurred by DNMT Aberration Promotes Pancreatic Cancer Progression; 2024. 586: p. 216611.","DOI":"10.1016\/j.canlet.2024.216611"},{"key":"10.1016\/j.coi.2025.102581_bib15","doi-asserted-by":"crossref","unstructured":"Schmidt, AD and C.J.E.D. de Guzman Strong: Current Understanding of Epigenetics in Atopic Dermatitis. 2021. 30(8): p. 1150\u20131155.","DOI":"10.1111\/exd.14392"},{"key":"10.1016\/j.coi.2025.102581_bib16","doi-asserted-by":"crossref","unstructured":"Harioudh, MK, et al.: Oligoadenylate Synthetase 1 Displays Dual Antiviral Mechanisms in Driving Translational Shutdown and Protecting Interferon Production. 2024. 57(3): p. 446\u2013461. e7.","DOI":"10.1016\/j.immuni.2024.02.002"},{"key":"10.1016\/j.coi.2025.102581_bib17","doi-asserted-by":"crossref","unstructured":"Jin, SP, et al.: Mapping the Immune Cell Landscape of Severe Atopic Dermatitis by Single-Cell RNA-seq; 2024. 79(6): p. 1584\u20131597.","DOI":"10.1111\/all.16121"},{"key":"10.1016\/j.coi.2025.102581_bib18","doi-asserted-by":"crossref","unstructured":"Miyagawa, F, et al.: Type I IFN Derived From Ly6Chi Monocytes Suppresses Type 2 Inflammation in a Murine Model of Atopic Dermatitis; 2024. 144(3): p. 520\u2013530. e2.","DOI":"10.1016\/j.jid.2023.08.022"},{"key":"10.1016\/j.coi.2025.102581_bib19","doi-asserted-by":"crossref","unstructured":"Liang, Y, et al.: Demethylation of the FCER1G Promoter Leads to Fc\u03b5RI Overexpression on Monocytes of Patients With Atopic Dermatitis. 2012. 67(3): p. 424\u2013430.","DOI":"10.1111\/j.1398-9995.2011.02760.x"},{"key":"10.1016\/j.coi.2025.102581_bib20","doi-asserted-by":"crossref","unstructured":"Gibson, F, et al.: Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases; 2022. 63(3): p. 447\u2013471.","DOI":"10.1007\/s12016-022-08956-8"},{"key":"10.1016\/j.coi.2025.102581_bib21","doi-asserted-by":"crossref","unstructured":"Sugita, KJJA and C Immunology: Adipose Tissue Remodeling Via TSLP-Mediated IL-4\/IL-13 Signaling: Implications for Atopic Dermatitis and Skin Barrier; 2024. 154(2): p. 282\u2013284.","DOI":"10.1016\/j.jaci.2024.06.002"},{"key":"10.1016\/j.coi.2025.102581_bib22","doi-asserted-by":"crossref","unstructured":"Luo, Y., et al.: Promoter Demethylation Contributes to TSLP Overexpression in Skin Lesions of Patients With Atopic Dermatitis; 2014. 39(1): p. 48\u201353.","DOI":"10.1111\/ced.12206"},{"key":"10.1016\/j.coi.2025.102581_sbref3","series-title":"Seminars in Cell & Developmental Biology","article-title":"Epigenetic control of inflammation in atopic dermatitis","author":"Akhtar","year":"2024"},{"key":"10.1016\/j.coi.2025.102581_bib24","doi-asserted-by":"crossref","unstructured":"Liang, Y, et al.: Thymic Stromal Lymphopoietin Epigenetically Upregulates Fc Receptor \u03b3 Subunit\u2013Related Receptors on Antigen-Presenting Cells and Induces TH2\/TH17 Polarization Through Dectin-2; 2019. 144(4): p. 1025\u20131035. e7.","DOI":"10.1016\/j.jaci.2019.06.011"},{"key":"10.1016\/j.coi.2025.102581_bib25","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez-Enr\u00edquez, E and JJF Hallgren: Mast Cells and Their Progenitors in Allergic Asthma; 2019. 10: p. 821.","DOI":"10.3389\/fimmu.2019.00821"},{"key":"10.1016\/j.coi.2025.102581_bib26","doi-asserted-by":"crossref","unstructured":"Acevedo, N, et al.: Epigenetic Alterations in Skin Homing CD4+ CLA+ T Cells of Atopic Dermatitis Patients; 2020. 10(1): p. 18020.","DOI":"10.1038\/s41598-020-74798-z"},{"key":"10.1016\/j.coi.2025.102581_bib27","doi-asserted-by":"crossref","unstructured":"Kim, JE, et al.: Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic Dermatitis; 2016. 17(8): p. 1234.","DOI":"10.3390\/ijms17081234"},{"key":"10.1016\/j.coi.2025.102581_bib28","doi-asserted-by":"crossref","unstructured":"Rodriguez, E, et al.: An Integrated Epigenetic and Transcriptomic Analysis Reveals Distinct Tissue-Specific Patterns of DNA Methylation Associated With Atopic Dermatitis; 2014. 134(7): p. 1873\u20131883.","DOI":"10.1038\/jid.2014.87"},{"key":"10.1016\/j.coi.2025.102581_bib29","doi-asserted-by":"crossref","unstructured":"Berkowitz, JS, et al.: Cell Type\u2013Specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell-Intrinsic and Cell-Extrinsic Circuits; 2023. 75(10): p. 1819\u20131830.","DOI":"10.1002\/art.42536"},{"key":"10.1016\/j.coi.2025.102581_bib30","doi-asserted-by":"crossref","unstructured":"da Silva Duarte, AJ and SS Sanabani: Deciphering Epigenetic Regulations in the Inflammatory Pathways of Atopic Dermatitis; 2024: p. 122713.","DOI":"10.1016\/j.lfs.2024.122713"},{"key":"10.1016\/j.coi.2025.102581_bib31","doi-asserted-by":"crossref","unstructured":"Ferrer, J and N Dimitrova: Transcription Regulation by Long Non-Coding RNAs: Mechanisms and Disease Relevance; 2024. 25(5): p. 396\u2013415.","DOI":"10.1038\/s41580-023-00694-9"},{"key":"10.1016\/j.coi.2025.102581_bib32","doi-asserted-by":"crossref","unstructured":"Zhang, W, Y He, and YJPR Zhang: CircRNA in Ocular Neovascular Diseases: Fundamental Mechanism and Clinical Potential; 2023: p. 106946.","DOI":"10.1016\/j.phrs.2023.106946"},{"key":"10.1016\/j.coi.2025.102581_bib33","doi-asserted-by":"crossref","unstructured":"Wang, R., et al.: Shear-Sensitive circRNA-LONP2 Promotes Endothelial Inflammation and Atherosclerosis by Targeting NRF2\/HO1 Signaling; 2024. 9(5): p. 652\u2013670.","DOI":"10.1016\/j.jacbts.2024.02.019"},{"key":"10.1016\/j.coi.2025.102581_bib34","doi-asserted-by":"crossref","unstructured":"Huang, D., et al.: Tumour Circular RNAs Elicit Anti-Tumour Immunity by Encoding Cryptic Peptides; 2024. 625(7995): p. 593\u2013602.","DOI":"10.1038\/s41586-023-06834-7"},{"key":"10.1016\/j.coi.2025.102581_bib35","doi-asserted-by":"crossref","unstructured":"Mehta, A and D Baltimore: MicroRNAs as Regulatory Elements in Immune System Logic; 2016. 16(5): p. 279\u2013294.","DOI":"10.1038\/nri.2016.40"},{"key":"10.1016\/j.coi.2025.102581_bib36","doi-asserted-by":"crossref","unstructured":"Ghafouri-Fard, S, et al.: Emerging Role of Non-Coding RNAs in Allergic Disorders; 2020. 130: p. 110615.","DOI":"10.1016\/j.biopha.2020.110615"},{"key":"10.1016\/j.coi.2025.102581_bib37","doi-asserted-by":"crossref","unstructured":"Pa\u017eur, K, et al.: Proteomic, miRNA and Bacterial Biomarker Patterns in Atopic Dermatitis Patients and Their Course Upon Anti-IL-4R\u03b1 Therapy; 2024. 38(9): p. 1749\u20131759.","DOI":"10.1111\/jdv.19911"},{"key":"10.1016\/j.coi.2025.102581_bib38","doi-asserted-by":"crossref","unstructured":"Yang, L, et al.: Hsa_circ_0004287 Inhibits Macrophage-Mediated Inflammation in an N6-Methyladenosine\u2013Dependent Manner in Atopic Dermatitis and Psoriasis; 2022. 149(6): p. 2021\u20132033.","DOI":"10.1016\/j.jaci.2021.11.024"},{"key":"10.1016\/j.coi.2025.102581_bib39","doi-asserted-by":"crossref","unstructured":"B\u00e9langer, \u00c9, et al.: Eosinophil microRNAs Play a Regulatory Role in Allergic Diseases Included in the Atopic March; 2020. 21(23): p. 9011.","DOI":"10.3390\/ijms21239011"},{"key":"10.1016\/j.coi.2025.102581_bib40","doi-asserted-by":"crossref","unstructured":"Sonkoly, E, et al.: MiR-155 Is Overexpressed in Patients With Atopic Dermatitis and Modulates T-Cell Proliferative Responses by Targeting Cytotoxic T Lymphocyte\u2013Associated Antigen 4; 2010. 126(3): p. 581\u2013589. e20.","DOI":"10.1016\/j.jaci.2010.05.045"},{"key":"10.1016\/j.coi.2025.102581_bib41","doi-asserted-by":"crossref","unstructured":"Ma, L, et al.: MicroRNA-155 May Be Involved in the Pathogenesis of Atopic Dermatitis by Modulating the Differentiation and Function of T Helper Type 17 (Th17) Cells; 2015. 181(1): p. 142\u2013149.","DOI":"10.1111\/cei.12624"},{"key":"10.1016\/j.coi.2025.102581_bib42","doi-asserted-by":"crossref","unstructured":"Patrick, MT, et al.: Large-Scale Functional Inference for Skin-Expressing lncRNAs Using Expression and Sequence Information; 2023. 8(24).","DOI":"10.1172\/jci.insight.172956"},{"key":"10.1016\/j.coi.2025.102581_bib43","doi-asserted-by":"crossref","unstructured":"Rebane, A, et al.: MicroRNA-146a Alleviates Chronic Skin Inflammation in Atopic Dermatitis Through Suppression of Innate Immune Responses in Keratinocytes; 2014. 134(4): p. 836\u2013847. e11.","DOI":"10.1016\/j.jaci.2014.05.022"},{"key":"10.1016\/j.coi.2025.102581_bib44","doi-asserted-by":"crossref","unstructured":"Vaher, H, et al.: miR-10a-5p Is Increased in Atopic Dermatitis and Has Capacity to Inhibit Keratinocyte Proliferation. 2019. 74(11): p. 2146\u20132156.","DOI":"10.1111\/all.13849"},{"key":"10.1016\/j.coi.2025.102581_bib45","doi-asserted-by":"crossref","unstructured":"Moltrasio, C, M Romagnuolo, and AV Marzano: Epigenetic Mechanisms of Epidermal Differentiation; 2022. 23(9): p. 4874.","DOI":"10.3390\/ijms23094874"},{"key":"10.1016\/j.coi.2025.102581_bib46","doi-asserted-by":"crossref","unstructured":"Zhao, A, et al.: Role of Histone Modifications in Neurogenesis and Neurodegenerative Disease Development. 2024: p. 102324.","DOI":"10.1016\/j.arr.2024.102324"},{"key":"10.1016\/j.coi.2025.102581_bib47","doi-asserted-by":"crossref","unstructured":"Park, J, et al.: The Role of Histone Modifications: From Neurodevelopment to Neurodiseases; 2022. 7(1): p. 217.","DOI":"10.1038\/s41392-022-01078-9"},{"key":"10.1016\/j.coi.2025.102581_bib48","doi-asserted-by":"crossref","unstructured":"Tessarz, P and T Kouzarides: Histone Core Modifications Regulating Nucleosome Structure and Dynamics. 2014. 15(11): p. 703\u2013708.","DOI":"10.1038\/nrm3890"},{"key":"10.1016\/j.coi.2025.102581_bib49","article-title":"A Dysregulated Sebum\u2013Microbial Metabolite\u2013IL-33 Axis Initiates Skin Inflammation in Atopic Dermatitis","volume":"219","author":"Qiu","year":"2022"},{"key":"10.1016\/j.coi.2025.102581_othref0230","doi-asserted-by":"crossref","unstructured":"Wang, J., et al.: Pathogenesis of Allergic Diseases and Implications for Therapeutic Interventions; 2023. 8(1): p. 138.","DOI":"10.1038\/s41392-023-01344-4"},{"key":"10.1016\/j.coi.2025.102581_bib51","doi-asserted-by":"crossref","unstructured":"Alaskhar Alhamwe, B, et al.:\u00a0Histone Modifications and Their Role in Epigenetics of Atopy and Allergic Diseases; 2018. 14: p. 1\u201316.","DOI":"10.1186\/s13223-018-0259-4"},{"key":"10.1016\/j.coi.2025.102581_bib52","doi-asserted-by":"crossref","unstructured":"Swarnkar, G., et al.: DNA Hypomethylation Ameliorates Erosive Inflammatory Arthritis by Modulating Interferon Regulatory Factor-8; 2024. 121(7): p. e2310264121.","DOI":"10.1073\/pnas.2310264121"},{"key":"10.1016\/j.coi.2025.102581_bib53","doi-asserted-by":"crossref","unstructured":"Pereira da Costa, R., et al.: Case Report: VEXAS Syndrome: An Atypical Indolent Presentation as Sacroiliitis With Molecular Response to Azacitidine; 2024. 15: p. 1403808.","DOI":"10.3389\/fimmu.2024.1403808"},{"key":"10.1016\/j.coi.2025.102581_bib54","doi-asserted-by":"crossref","unstructured":"Alfardan, AS, et al.: DNMT Inhibitor, 5-Aza-2\u2032-Deoxycytidine Mitigates di (2-Ethylhexyl) Phthalate-Induced Aggravation of Psoriasiform Inflammation in Mice Via Reduction in Global DNA Methylation in Dermal and Peripheral Compartments; 2024. 137: p. 112503.","DOI":"10.1016\/j.intimp.2024.112503"},{"key":"10.1016\/j.coi.2025.102581_bib55","doi-asserted-by":"crossref","unstructured":"Li, H, et al.: Precision DNA Demethylation Ameliorates Disease in Lupus-Prone Mice; 2018. 3(16).","DOI":"10.1172\/jci.insight.120880"},{"key":"10.1016\/j.coi.2025.102581_bib56","doi-asserted-by":"crossref","unstructured":"Liew, WC, et al.: Belinostat Resolves Skin Barrier Defects in Atopic Dermatitis by Targeting the Dysregulated miR-335: SOX6 Axis; 2020. 146(3): p. 606\u2013620. e12.","DOI":"10.1016\/j.jaci.2020.02.007"},{"key":"10.1016\/j.coi.2025.102581_bib57","doi-asserted-by":"crossref","unstructured":"Yu, X, et al.: MicroRNAs in Atopic Dermatitis: A Systematic Review; 2020. 24(11): p. 5966\u20135972.","DOI":"10.1111\/jcmm.15208"},{"key":"10.1016\/j.coi.2025.102581_bib58","doi-asserted-by":"crossref","unstructured":"Khosrojerdi, M, et al.: The Role of microRNAs in Atopic Dermatitis; 2024.","DOI":"10.5812\/jmb-151599"},{"key":"10.1016\/j.coi.2025.102581_bib59","doi-asserted-by":"crossref","unstructured":"Tsou, P-S, J Varga, and S O\u2019Reilly: Advances in Epigenetics in Systemic Sclerosis: Molecular Mechanisms and Therapeutic Potential; 2021. 17(10): p. 596\u2013607.","DOI":"10.1038\/s41584-021-00683-2"},{"key":"10.1016\/j.coi.2025.102581_othref0280","doi-asserted-by":"crossref","unstructured":"Fu, J, et al.: Emerging Progress of RNA-Based Antitumor Therapeutics; 2023. 19(10): p. 3159.","DOI":"10.7150\/ijbs.83732"},{"key":"10.1016\/j.coi.2025.102581_othref0285","doi-asserted-by":"crossref","unstructured":"Chang, Y-T, et al.: Small Interfering RNA-Based Nanotherapeutics for Treating Skin-Related Diseases; 2023. 20(6): p. 757\u2013772.","DOI":"10.1080\/17425247.2023.2206646"},{"key":"10.1016\/j.coi.2025.102581_othref0290","doi-asserted-by":"crossref","unstructured":"Kleaveland, BJC:\u00a0SnapShot: target-directed miRNA degradation; 2023. 186(25): p. 5674\u20135674. e1.","DOI":"10.1016\/j.cell.2023.11.020"},{"key":"10.1016\/j.coi.2025.102581_bib63","doi-asserted-by":"crossref","unstructured":"Migliore, L and F Copped\u00e8: Gene\u2013Environment Interactions in Alzheimer Disease: The Emerging Role of Epigenetics; 2022. 18(11): p. 643\u2013660.","DOI":"10.1038\/s41582-022-00714-w"},{"key":"10.1016\/j.coi.2025.102581_othref0300","doi-asserted-by":"crossref","unstructured":"Danieli, MG, et al.: Exposome: Epigenetics and Autoimmune Diseases; 2024: p. 103584.","DOI":"10.1016\/j.autrev.2024.103584"},{"key":"10.1016\/j.coi.2025.102581_othref0305","doi-asserted-by":"crossref","unstructured":"Eshleman, EM, et al.: Microbiota-Derived Butyrate Restricts Tuft Cell Differentiation Via Histone Deacetylase 3 to Modulate Intestinal Type 2 Immunity. 2024. 57(2): p. 319\u2013332.e6.","DOI":"10.1016\/j.immuni.2024.01.002"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525000573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525000573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:03:30Z","timestamp":1779084210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525000573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":65,"alternative-id":["S0952791525000573"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102581","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetics of atopic dermatitis: pathogenesis and therapeutic prospects","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102581"}}